Abul Kalam Azad

Title: Abul Kalam Azad: Innovator in Pharmaceutical Composition

Introduction

Abul Kalam Azad is a notable inventor based in Pierrefonds, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized compositions for nonsteroidal anti-inflammatory drugs (NSAIDs). With a total of 2 patents, his work has the potential to enhance the efficacy and safety of pain management therapies.

Latest Patents

Azad's latest patents focus on a stabilized pharmaceutical composition that combines an NSAID with a prostaglandin. This innovative composition is designed for oral administration and features a solid dosage form where the NSAID is enterically coated. The inclusion of a stabilizing agent, such as hydroxypropyl methylcellulose or polyvinylpyrrolidone, ensures the stability of the prostaglandin. Notably, exemplary dosage forms include bilayer tablets containing misoprostol as the prostaglandin and diclofenac or piroxicam as the NSAID. The methods outlined in his patents aim to treat various NSAID-responsive conditions, disorders, and diseases effectively.

Career Highlights

Abul Kalam Azad is associated with Pharmascience Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving patient outcomes through advanced drug formulations.

Collaborations

Azad collaborates with Aomar Ouali, contributing to the development of cutting-edge pharmaceutical solutions.

Conclusion

Abul Kalam Azad's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a significant inventor in the industry. His work promises to advance the treatment options available for patients requiring NSAID therapies.